Real-World Experience With Dalbavancin Therapy in Gram-Positive Skin and Soft Tissue Infection, Bone and Joint Infection
Infection - Germany
doi 10.1007/s15010-019-01354-x
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2019
Authors
Publisher
Springer Science and Business Media LLC